ID   A549-ESM
AC   CVCL_XI06
SY   A549-MSB
DR   cancercelllines; CVCL_XI06
DR   Wikidata; Q93311939
RX   Patent=WO1999045028A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1972.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: HGNC; 3466; ESM1.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 8
//
RX   Patent=WO1999045028A1;
RA   Lassalle P., Marchandise G., Kervoaze G., Tonnel A.-B.;
RT   "Monoclonal antibodies ESM-1 protein specific, and use of said
RT   antibodies for detecting ESM-1 protein.";
RL   Patent number WO1999045028A1, 10-Sep-1999.
//